Condition
Sézary Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02836886Completed
VircapSeq Virus Detection in Sézary Syndrome
NCT02811783Phase 3Terminated
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
NCT02822586Phase 1Completed
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
NCT02542124Phase 2Unknown
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)
Showing all 4 trials